The S&P 500 gained 0.5% on Thursday, Jan. 23, reaching a record close as President Donald Trump pressed for lower oil prices ...

Moderna Inc (MRNA) stock saw a modest uptick, ending the day at $38.5 which represents a slight increase of $2.61 or 7.27% from the prior close of $35.89. The stock opened at $36.35 and touched a low ...

A hearing on RFK Jr.'s appointment as HHS secretary has stalled; physicians protest his appointment and Trump has paused communications.

Now, it’s worth noting Stock Advisor’s total average return is 894% — a market-crushing outperformance compared to 176% for ...

There are many criteria dividend investors can use to narrow down the list of available exchange-traded funds, or ETFs. Dividend yield — the annual dividends paid by an asset divided by its ...

Key Takeaways U.S. equities rose at midday Tuesday on optimism that the new tariffs threatened by President Trump won't be as ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...

RNA vaccine developer Moderna (MRNA) is climbing nearly 5% in early trading today after it was awarded about $590 million by the U.S.

The Danish renewable-energy company said late Monday that its Sunrise Wind project off the coast of New York is navigating supply chain and construction challenges, which have resulted in delays and ...

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Moderna Inc (MRNA) stock saw a decline, ending the day at $33.76 which represents a decrease of $-1.01 or -2.90% from the prior close of $34.77. The stock opened at $34.75 and touched a low of $33.34 ...